Vefa İlaç San. ve Tic. A.Ş.
İstanbul · Beylikdüzü
Vefa İlaç San. ve Tic. A.Ş.
Vefa İlaç was founded in 2012 with Ministry of Health production approvals and obtained GMP certification in 2013 for pharmaceuticals and food supplements.
About
Our strategy: To carry out the production and export of our pharmaceutical and food supplement products, which provide additional benefits in the sector, for all foreign markets.
Our mission: To offer its customers a high quality and wide range of medicines, traditional herbal medicines, food supplements and personal care products with the latest technology, with the right strategy that brings together the health sector between continents.
Our vision: Thanks to its success in Pharmaceutical/Traditional-Herbal Product/Food Supplement production and R&D; To be one of the rapidly growing companies in the field of export.
2012 June: Permission and approvals were obtained for the production of pharmaceuticals and food supplements from the ministry of health. 2012 September: Vefa Ilac San Ve Tic.Ltd.Şti as manufactures was founded in Beylikdüzü Mermerciler Organize Sanayi Sitesi in Istanbul. 2013 August: Our company was ready to produce and his GMP certification was approved by the ministry of health. 2013 September: Our factory was opened with the participation of helath minister DR.Mehmet Müezzinoğlu in 2013.
Production profile
Company type
Activity types
Production capabilities
Machine park
Manufacturing processes
Certifications
Export profile
Industries served
Activity categories
Target export markets
Azerbaijan
Georgia
Saudi Arabia
United Arab Emirates
Romania
Albania
Bosnia and Herzegovina
Croatia
Switzerland
Turkmenistan
Map
Location is approximate, based on the address. · © OpenStreetMap
Factory gallery
Products
D-Colefor 20000 IU Soft Capsules
D-Colefor is a 14-soft-capsule pack of 20,000 IU vitamin D3 (cholecalciferol). Vefa İlaç’s production page states that softgels are made in a closed gelatin system on a touch-free soft-gel encapsulation machine. Annual solid capacity is published as 1,425,000,000 tablets, film-coated tablets, capsules and softgels. The plant holds WHO GMP (pharmaceutical) and ISO 9001:2015; the R&D lab prepares CTD dossiers and QbD (Quality by Design) work.
Elfenor 5% Gel 50 g
ELFENOR is a 5% topical NSAID gel whose active substance is diclofenac sodium. It is supplied in 50 g tubes for musculoskeletal and joint pain applied to the skin. Vefa İlaç publishes annual semi-solid (cream, ointment, gel) capacity of 15,000,000 units. Quality control is performed by specialised staff in a plant equipped with selected latest-generation machines; the licence address is Mermerciler San. Sit. 2nd Street No:3, Beylikdüzü.
Refcon Advance Oral Suspension 200 ml
REFCON ADVANCE is an oral suspension with 100.00 mg sodium alginate and 20.00 mg potassium bicarbonate per ml. It is an opaque off-white, mint-scented viscous suspension supplied in an amber 200 ml glass bottle with a 15 ml measuring cup. The package leaflet places it in the reflux (oesophagitis) suppressant group for heartburn and oesophageal-reflux symptoms. The marketing authorisation holder is Vefa İlaç; production is at the 6,000 m² indoor / 8,000 m² total plant in Beylikdüzü Mermerciler OSB, 2nd Street No:3.
Services
R&D (Galenic and Analytical)
The R&D laboratory has two main units: galenic and analytical. Patent screening, API evaluation, formulation and analytical-method development, process and analytical-method validation, product improvement, new-product stability and CTD dossier preparation are run under QbD (Quality by Design). Vefa İlaç aims to develop innovative products, high-success bioequivalence studies and common CTD files for Turkey and other countries; the R&D lab also runs joint TUBITAK projects.
Pharmaceutical and Food-Supplement Manufacturing
The Vefa İlaç plant stands on 8,000 m² in total, of which 6,000 m² is indoor. Published annual capacities are 1,425,000,000 solid units (tablets, film-coated tablets, capsules, softgels), 48,000,000 syrups and 15,000,000 creams, ointments and gels. In the soft-gel centre, gelatins run in a closed system and the fill is encapsulated without hand contact. The site holds a WHO GMP (pharmaceutical) certificate.
Quality Control
The plant is described as equipped with selected latest-generation machines and instruments. Quality control is performed by specialised staff. The Ministry of Health GMP inspection was passed in August 2013; production continues under WHO GMP (pharmaceutical) and ISO 9001:2015. Process and analytical-method validations and new-product stability studies are defined on the R&D and production page as part of the quality system.